A convergence of biological risks

AxiosAugust 14, 2026en

What's the common thread connecting AI advances, biological breakthroughs, a preponderance of high-risk-high-reward research, escalating geopolitical tensions and a hollowed-out U.S. public health sector? They all heighten the risk that one day a lethal human-made pathogen will emerge, either accidentally or intentionally, and we won't be ready for it. Why it matters: The same advances that make this a pivotal moment for medical innovation are intensifying the risk of catastrophic lab mishaps, though how significant a risk is hotly debated by experts. "It is a very small tweak from trying to target a disease, and making gene therapies to try to target a disease, to turning a virus into somet

This is a short summary published by AI Global Wire. The full article is owned and hosted by Axios — open it there to read it in full.

• Forskning